Exane Derivatives’s CareTrust REIT CTRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-49,805
Closed -$1.01M 900
2021
Q3
$1.01M Sell
49,805
-6,686
-12% -$151K 0.24% 88
2021
Q2
$1.34M Buy
56,491
+984
+2% +$23.2K 0.3% 71
2021
Q1
$1.29M Buy
55,507
+2,275
+4% +$52.2K 0.37% 64
2020
Q4
$1.18M Buy
+53,232
New +$1.05M 0.35% 62
2020
Q3
Sell
-6,414
Closed -$110K 757
2020
Q2
$110K Buy
+6,414
New +$112K 0.03% 280

Other funds holding CTRE

Exane Derivatives's CTRE Position: Q4 2021 in Review

Exane Derivatives sold out of CareTrust REIT (CTRE) in Q4 2021, closing a stake of 49,805 shares — an estimated $1.01M sold.

Exane Derivatives first reported a position in CTRE in Q2 2020 and held it in 5 quarters. The position peaked at $1.34M in Q2 2021. 242 funds tracked by Wall St. Rank hold CTRE as of Q4 2021.

  • Exane Derivatives reported no remaining CareTrust REIT position as of Q4 2021 after selling out during the quarter.
  • Exane Derivatives sold 49,805 CareTrust REIT shares in Q4 2021, an estimated $1.01M.
  • Exane Derivatives first reported a position in CareTrust REIT in Q2 2020 and held it in 5 quarters.
  • Exane Derivatives's CareTrust REIT position peaked at $1.34M in Q2 2021.
  • 242 funds tracked by Wall St. Rank held CareTrust REIT as of Q4 2021.

Based on Exane Derivatives's 13F filing for Q4 2021, filed 28 Jan 2022.